当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Botox
儿科标签批准日期
2018/9/12 0:00:00
特定指示/秒
Prevention of headaches in adolescents with chronic migraine
标签更改摘要
- Safety and effectiveness in patients below the age of 18 years have not been established.
- In a 12-week, multicenter, double-blind, placebo-controlled clinical trial, 123 adolescent patients (ages 12 to below 18 years) with chronic migraine were randomized to receive Botox 74 Units, Botox 155 Units, or placebo, for one injection cycle. This trial did not establish the efficacy of Botox, compared with placebo, for the prophylaxis of headaches in adolescents with chronic migraine.
- Postmarketing study.
研究设计
Placebo,Single-Blind,Parallel Group